Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Urogenital Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Hematopoietic and Lymphoid System Neoplasm 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

Gemcitabine 6Irinotecan 5Oxaliplatin 4Magnetic Resonance Spectroscopy 4Surgical Procedures, Operative 3Specimen Handling 3Leucovorin 3Fluorouracil 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3palbociclib 2olaparib 2cobimetinib 2Radiosurgery 2Positron-Emission Tomography 2Oncolytic Virotherapy 2Nivolumab 2Ketamine 2Immunoglobulin G 2Immune Checkpoint Inhibitors 2Disulfides 2Cyclophosphamide 2Capecitabine 2Biopsy 2tremelimumab 1trastuzumab biosimilar HLX02 1toripalimab 1sonidegib 1pimonidazole 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Pancreatic Neoplasms × Genetic Testing × Clear all
NCT04067960 2024-08-14

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Mayo Clinic

Phase EARLY_PHASE1 Completed
197 enrolled
CNSGastrointestinalGenitourinaryGynecologic

Brain Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡